BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 23588954)

  • 1. Narrowing racial gaps in breast cancer chemotherapy initiation: the role of the patient-provider relationship.
    Sheppard VB; Isaacs C; Luta G; Willey SC; Boisvert M; Harper FW; Smith K; Horton S; Liu MC; Jennings Y; Hirpa F; Snead F; Mandelblatt JS
    Breast Cancer Res Treat; 2013 May; 139(1):207-16. PubMed ID: 23588954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initiation of Adjuvant Endocrine Therapy in Black and White Women With Breast Cancer.
    Sheppard VB; de Mendoza AH; He J; Jennings Y; Edmonds MC; Oppong BA; Tadesse MG
    Clin Breast Cancer; 2018 Oct; 18(5):337-346.e1. PubMed ID: 29422259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of timing of adjuvant chemotherapy initiation and completion after surgery on racial disparities in survival among women with breast cancer.
    Nurgalieva ZZ; Franzini L; Morgan RO; Vernon SW; Liu CC; Du XL
    Med Oncol; 2013 Mar; 30(1):419. PubMed ID: 23292872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlates of Triple Negative Breast Cancer and Chemotherapy Patterns in Black and White Women With Breast Cancer.
    Sheppard VB; Cavalli LR; Dash C; Kanaan YM; Dilawari AA; Horton S; Makambi KH
    Clin Breast Cancer; 2017 Jun; 17(3):232-238. PubMed ID: 28189497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receipt of adjuvant endometrial cancer treatment according to race: an NRG Oncology/Gynecologic Oncology Group 210 Study.
    Felix AS; Cohn DE; Brasky TM; Zaino R; Park K; Mutch DG; Creasman WT; Thaker PH; Walker JL; Moore RG; Lele SB; Guntupalli SR; Downs LS; Nagel CI; Boggess JF; Pearl ML; Ioffe OB; Randall ME; Brinton LA
    Am J Obstet Gynecol; 2018 Nov; 219(5):459.e1-459.e11. PubMed ID: 30096321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disparities in breast cancer surgery delay: the lingering effect of race.
    Sheppard VB; Oppong BA; Hampton R; Snead F; Horton S; Hirpa F; Brathwaite EJ; Makambi K; Onyewu S; Boisvert M; Willey S
    Ann Surg Oncol; 2015 Sep; 22(9):2902-11. PubMed ID: 25652051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Adjuvant Hormone Therapy Timing With Overall Survival Among Patients With Hormone Receptor-Positive Human Epidermal Growth Factor Receptor-2-Negative Early Breast Cancer Without Chemotherapy.
    Fu F; Yu L; Zeng B; Chen M; Guo W; Chen L; Lin Y; Hou J; Li J; Li Y; Li S; Chen X; Zhang W; Jin X; Cai W; Zhang K; Chen H; Qiu Y; Nie Q; Wang C; Jacobs L
    JAMA Netw Open; 2022 Feb; 5(2):e2145934. PubMed ID: 35166783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing Perceived Discrimination as Reported by Black and White Women Diagnosed with Breast Cancer.
    Sutton AL; Hagiwara N; Perera RA; Sheppard VB
    J Racial Ethn Health Disparities; 2021 Jun; 8(3):589-595. PubMed ID: 32808196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Narrowing Racial Gaps in Breast Cancer: Factors Affecting Probability of Adjuvant Radiation Therapy.
    Snead F; Slade AN; Oppong BA; Sutton AL; Sheppard VB
    Adv Radiat Oncol; 2020; 5(1):17-26. PubMed ID: 32051886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with receipt of breast cancer adjuvant chemotherapy in a diverse population-based sample.
    Griggs JJ; Hawley ST; Graff JJ; Hamilton AS; Jagsi R; Janz NK; Mujahid MS; Friese CR; Salem B; Abrahamse PH; Katz SJ
    J Clin Oncol; 2012 Sep; 30(25):3058-64. PubMed ID: 22869890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Racial differences in receipt of adjuvant hormonal therapy among Medicaid enrollees in South Carolina diagnosed with breast cancer.
    Felder TM; Do DP; Lu ZK; Lal LS; Heiney SP; Bennett CL
    Breast Cancer Res Treat; 2016 May; 157(1):193-200. PubMed ID: 27120468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. More than treatment refusal: a National Cancer Database analysis of adjuvant treatment refusal and racial survival disparities among women with endometrial cancer.
    Barrington DA; Sinnott JA; Nixon D; Padamsee TJ; Cohn DE; Doll KM; Donneyong MM; Felix AS
    Am J Obstet Gynecol; 2022 Aug; 227(2):244.e1-244.e17. PubMed ID: 35283091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A tracking and feedback registry to reduce racial disparities in breast cancer care.
    Bickell NA; Shastri K; Fei K; Oluwole S; Godfrey H; Hiotis K; Srinivasan A; Guth AA
    J Natl Cancer Inst; 2008 Dec; 100(23):1717-23. PubMed ID: 19033569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Racial disparities in omission of oncotype DX but no racial disparities in chemotherapy receipt following completed oncotype DX test results.
    Press DJ; Ibraheem A; Dolan ME; Goss KH; Conzen S; Huo D
    Breast Cancer Res Treat; 2018 Feb; 168(1):207-220. PubMed ID: 29181717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delays in adjuvant chemotherapy treatment among patients with breast cancer are more likely in African American and Hispanic populations: a national cohort study 2004-2006.
    Fedewa SA; Ward EM; Stewart AK; Edge SB
    J Clin Oncol; 2010 Sep; 28(27):4135-41. PubMed ID: 20697082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring Racial Differences in Patient Centeredness of Care (PCC) During Breast Cancer (BC) Chemotherapy Clinical Visits.
    Robertson-Jones TA; Tissue MM; Connolly M; Gallups SF; Bender CM; Rosenzweig MQ
    J Racial Ethn Health Disparities; 2019 Feb; 6(1):94-100. PubMed ID: 29971577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Residual treatment disparities after oncology referral for rectal cancer.
    Morris AM; Billingsley KG; Hayanga AJ; Matthews B; Baldwin LM; Birkmeyer JD
    J Natl Cancer Inst; 2008 May; 100(10):738-44. PubMed ID: 18477800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial disparities in initiation of adjuvant endocrine therapy of early breast cancer.
    Reeder-Hayes KE; Meyer AM; Dusetzina SB; Liu H; Wheeler SB
    Breast Cancer Res Treat; 2014 Jun; 145(3):743-51. PubMed ID: 24789443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reducing Racial Disparities in Breast Cancer Survivors' Ratings of Quality Cancer Care: The Enduring Impact of Trust.
    Sheppard VB; Hurtado-de-Mendoza A; Talley CH; Zhang Y; Cabling ML; Makambi KH
    J Healthc Qual; 2016; 38(3):143-63. PubMed ID: 27152910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in treatment and survival among African-American and Caucasian women with early stage operable breast cancer.
    Sail K; Franzini L; Lairson D; Du X
    Ethn Health; 2012; 17(3):309-23. PubMed ID: 22066691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.